Evaluating Clorox: Insights From 12 Financial Analysts
Portfolio Pulse from Benzinga Insights
Over the past three months, 12 analysts have evaluated Clorox (NYSE:CLX), showing a range of sentiments from indifferent to somewhat bearish. The average 12-month price target has decreased by 4.23% to $147.92. Recent analyst actions include several downgrades and lowered price targets, reflecting concerns over Clorox's financial performance, including declining revenue, negative net margin, and high debt levels.
June 24, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Clorox has received mixed analyst ratings over the past three months, with a notable decrease in the average 12-month price target by 4.23% to $147.92. Analysts have downgraded their ratings and lowered price targets, citing financial challenges such as declining revenue, negative net margin, and high debt levels.
The decrease in the average price target and multiple downgrades by analysts indicate a negative short-term outlook for Clorox. Financial challenges such as declining revenue, negative net margin, and high debt levels further support the likelihood of a downward price movement.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100